Prognostic Factors for Recurrence After Pulmonary Resection of Colorectal Cancer Metastases

Annals of Thoracic Surgery

Volumn 87, Issue 6, 2009, Pages 1684-1688

  Onaitis, Mark W ^a   Petersen, Rebecca P ^a   Haney, John C ^a   Saltz, Leonard ^b   Park, Bernard ^b   Flores, Raja ^b   Rizk, Nabil ^b   Bains, Manjit S ^b   Dycoco, Joseph ^b   D'Amico, Thomas A ^a   Harpole, David H ^a   Kemeny, Nancy ^b   Rusch, Valerie W ^b   Downey, Robert ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; HUMAN; LUNG METASTASIS; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECTUM CANCER; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 65649102711     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.03.034     Document Type: Article

References (22)

1. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113 (1997) 37-49
2. Girard P., Ducreux M., Baldeyrou P., et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol 14 (1996) 2047-2053
3. Inoue M., Ohta M., Iuchi K., et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 78 (2004) 238-244
4. McAfee M.K., Allen M.S., Trastek V.F., Ilstrup D.M., Deschamps C., and Pairolero P.C. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 53 (1992) 780-786
5. McCormack P.M., Burt M.E., Bains M.S., Martini N., Rusch V.W., and Ginsberg R.J. Lung resection for colorectal metastases. 10-year results. Arch Surg 127 (1992) 1403-1406
6. Okumura S., Kondo H., Tsuboi M., et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 112 (1996) 867-874
7. Pfannschmidt J., Muley T., Hoffmann H., and Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 126 (2003) 732-739
8. Rena O., Casadio C., Viano F., et al. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. Eur J Cardiothorac Surg 21 (2002) 906-912
9. Saito Y., Omiya H., Kohno K., et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 124 (2002) 1007-1013
10. Vogelsang H., Haas S., Hierholzer C., Berger U., Siewert J.R., and Präuer H. Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91 (2004) 1066-1071
11. Welter S., Jacobs J., Krbek T., Poettgen C., and Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 31 (2007) 167-172
12. Yedibela S., Klein P., Feuchter K., et al. Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol 13 (2006) 1538-1544
13. Zink S., Kayser G., Gabius H.J., and Kayser K. Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases. Eur J Cardiothorac Surg 19 (2001) 908-913
14. Saltz L.B., Cox J.V., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343 (2000) 905-914
15. Goldberg R.M., Sargent D.J., Morton R.F., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22 (2004) 23-30
16. Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
17. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
18. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-321
19. Gayowski T.J., Iwatsuki S., Madariaga J.R., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116 (1994) 703-711
20. Rosen C.B., Nagorney D.M., Taswell H.F., et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216 (1992) 493-505
21. Scheele J., Stang R., Altendorf-Hofmann A., and Paul M. Resection of colorectal liver metastases. World J Surg 19 (1995) 59-71
22. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371 (2008) 1007-1016